The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
A member of the class of indazoles carrying benzyl and 3-(dimethylamino)propyl groups at positions 1 and 3 respectively. A locally-acting nonsteroidal anti-inflammatory drug that also exhibits local anaesthetic and analgesic properties.
FMO1 protein results in increased oxidation of Benzydamine Benzydamine inhibits the reaction [FMO1 protein results in increased chemical synthesis of clozapine N-oxide]
FMO2 protein results in increased oxidation of Benzydamine [FMO2 protein results in increased oxidation of Benzydamine] which results in increased chemical synthesis of benzydamine N-oxide
Benzydamine inhibits the reaction [FMO3 protein results in increased chemical synthesis of clozapine N-oxide] FMO3 gene polymorphism affects the metabolism of Benzydamine FMO3 protein results in increased metabolism of Benzydamine FMO3 protein results in increased oxidation of Benzydamine